Rhythm Pharmaceuticals Inc (RYTM)
39.06
+0.60
(+1.56%)
USD |
NASDAQ |
May 10, 16:00
39.06
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Market Cap: 2.382B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.345B |
| May 08, 2024 | 2.373B |
| May 07, 2024 | 2.399B |
| May 06, 2024 | 2.675B |
| May 03, 2024 | 2.668B |
| May 02, 2024 | 2.499B |
| May 01, 2024 | 2.526B |
| April 30, 2024 | 2.424B |
| April 29, 2024 | 2.367B |
| April 26, 2024 | 2.334B |
| April 25, 2024 | 2.326B |
| April 24, 2024 | 2.421B |
| April 23, 2024 | 2.439B |
| April 22, 2024 | 2.379B |
| April 19, 2024 | 2.317B |
| April 18, 2024 | 2.323B |
| April 17, 2024 | 2.344B |
| April 16, 2024 | 2.348B |
| April 15, 2024 | 2.444B |
| April 12, 2024 | 2.459B |
| April 11, 2024 | 2.596B |
| April 10, 2024 | 2.506B |
| April 09, 2024 | 2.659B |
| April 08, 2024 | 2.548B |
| April 05, 2024 | 2.472B |
| Date | Value |
|---|---|
| April 04, 2024 | 2.445B |
| April 03, 2024 | 2.493B |
| April 02, 2024 | 2.442B |
| April 01, 2024 | 2.602B |
| March 28, 2024 | 2.606B |
| March 27, 2024 | 2.513B |
| March 26, 2024 | 2.377B |
| March 25, 2024 | 2.385B |
| March 22, 2024 | 2.439B |
| March 21, 2024 | 2.444B |
| March 20, 2024 | 2.386B |
| March 19, 2024 | 2.353B |
| March 18, 2024 | 2.442B |
| March 15, 2024 | 2.406B |
| March 14, 2024 | 2.407B |
| March 13, 2024 | 2.464B |
| March 12, 2024 | 2.416B |
| March 11, 2024 | 2.436B |
| March 08, 2024 | 2.522B |
| March 07, 2024 | 2.506B |
| March 06, 2024 | 2.472B |
| March 05, 2024 | 2.480B |
| March 04, 2024 | 2.533B |
| March 01, 2024 | 2.629B |
| February 29, 2024 | 2.611B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
157.23M
Minimum
May 19 2022
3.116B
Maximum
Feb 12 2024
1.105B
Average
988.70M
Median
Sep 28 2020
Market Cap Benchmarks
| Pfizer Inc | 158.75B |
| Amicus Therapeutics Inc | 2.728B |
| Insmed Inc | 3.856B |
| Altimmune Inc | 512.22M |
| Regeneron Pharmaceuticals Inc | 107.19B |
Market Cap Related Metrics
| PS Ratio | 24.87 |
| PEG Ratio | -0.2208 |
| Price to Book Value | 38.67 |
| Price | 39.06 |
| Earnings Yield | -11.85% |
| PEGY Ratio | -0.2208 |